Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) FCF Margin (2016 - 2019)

Historic FCF Margin for Phio Pharmaceuticals (PHIO) over the last 8 years, with Q1 2019 value amounting to 10361.9%.

  • Phio Pharmaceuticals' FCF Margin fell 20706000.0% to 10361.9% in Q1 2019 from the same period last year, while for Dec 2019 it was 41509.52%, marking a year-over-year decrease of 360566300.0%. This contributed to the annual value of 2915.16% for FY2024, which is 3555515000.0% up from last year.
  • Phio Pharmaceuticals' FCF Margin amounted to 10361.9% in Q1 2019, which was down 20706000.0% from 3521.05% recorded in Q3 2018.
  • Over the past 5 years, Phio Pharmaceuticals' FCF Margin peaked at 3206.9% during Q2 2018, and registered a low of 29250.0% during Q1 2016.
  • Moreover, its 5-year median value for FCF Margin was 9326.6% (2018), whereas its average is 11974.34%.
  • Per our database at Business Quant, Phio Pharmaceuticals' FCF Margin soared by 52730200bps in 2015 and then crashed by -234264700bps in 2016.
  • Phio Pharmaceuticals' FCF Margin (Quarter) stood at 5823.53% in 2015, then plummeted by -255bps to 20666.67% in 2016, then rose by 29bps to 14673.33% in 2017, then surged by 76bps to 3521.05% in 2018, then tumbled by -194bps to 10361.9% in 2019.
  • Its FCF Margin was 10361.9% in Q1 2019, compared to 3521.05% in Q3 2018 and 3206.9% in Q2 2018.